America’s Food and Drug Administration (FDA) has approved a clinical trial of Envoy Medical’s Acclaim fully implanted cochlear implant, the...
Read moreThe links between hearing impairment, cognitive decline and dementia are receiving much attention as studies point to an association. Other...
Read moreEar Science Institute Australia is developing a world-first prosthetic eardrum based on silk fibroin biomaterial using silk spun from silkworms...
Read moreResearchers at the Bionics Institute in Melbourne have developed a world first test to objectively measure tinnitus with a brain...
Read moreResearchers have documented significant improvements in children and young adults with autism spectrum disorder (ASD) who underwent a short course...
Read moreA novel drug delivery system may prevent hearing damage during cancer treatment by transporting medications to the inner ear which...
Read moreNeuromod Devices is planning to make its Lenire device available in Australia and would partner with audiologists and ENTs experienced...
Read moreA German otorhinolaryngology research team has developed drug-eluting implants it hopes will be able to treat idiopathic sudden sensorineural hearing...
Read moreThe world’s first successful cochlear implant surgery in Melbourne 46 years ago made global headlines and changed the way hearing...
Read moreResearchers have developed a new optical coherence tomography (OCT) otoscope which they claim enhances diagnosis of ear disease and is...
Read moreHearing Practitioner Australia is the only independent business-to-business publication for the nation’s hearing industry. The multi-channel platform has been established out of the need for premium, local and independent content relevant to today’s audiologists, audiometrists, otolaryngologists/ENTs and other hearing professionals in Australia.
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited